OGN Organon & Co. Common Stock
$13,48
Prezzo · Giu 26, 2026
Fondamentali al Mag 4, 2026
Intervallo 52 sett.
$6–$13
100% of range
Rating Analisti
HOLD
13 analysts
Prezzo Obiettivo
$11
P/E (TTM)
10.0
ROE
25.2%
Margine di Profitto Netto
3.0%
OGN Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$13.47
Capitalizzazione di Mercato
$1.87B
P/E (TTM)
10.0
EPS (TTM)
$0.72
Ricavi (TTM)
$6.22B
Rendimento div.
4.7%
ROE
25.2%
D/E Debito/Patrimonio
11.5
Intervallo 52 sett.
$6 – $13
OGN Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$6.22B
2019-12-31
→
2025-12-31
EPS
$0.72
2019-12-31
→
2025-12-31
Flusso di cassa libero
$538M
2021-12-31
→
2025-12-31
Margini
3.0%
2024-12-31
→
2025-12-31
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
OGN
Mediana dei peer
P/E (TTM)
10.0
28.3
P/S (TTM)
0.3
3.9
P/B
2.5
3.4
Price / FCF (Prezzo / FCF)
3.5
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
OGN
Mediana dei peer
Gross Margin (Margine lordo)
53.3%
83.0%
Net Profit Margin (Margine di Profitto Netto)
3.0%
0.20%
ROA
1.4%
-7.4%
ROE
25.2%
-17.1%
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
OGN
Mediana dei peer
Debt / Equity (Debito / Patrimonio Netto)
11.5
13657.6
Current Ratio (Rapporto corrente)
1.8
3.5
Quick Ratio
0.8
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
OGN
Mediana dei peer
Revenue YoY (Ricavi YoY)
-2.9%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
0.23%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
-0.99%
—
EPS YoY
-78.4%
—
Net Income YoY (Utile Netto YoY)
-78.4%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
OGN
Mediana dei peer
Payout Ratio (Rapporto di Distribuzione Utili)
47.1%
—
Dividendi Rendimento, payout ratio, storico dividendi, CAGR 5Y
Dividend Yield
4.7%
Rapporto di Distribuzione Utili
47.1%
CAGR Dividendi 5Y
—
| Data ex-dividendo | Importo |
|---|---|
| 11 Maggio 2026 | $0,0200 |
| 23 Febbraio 2026 | $0,0200 |
| 20 Novembre 2025 | $0,0200 |
| 15 Agosto 2025 | $0,0200 |
| 12 Maggio 2025 | $0,0200 |
| 24 Febbraio 2025 | $0,2800 |
| 12 Novembre 2024 | $0,2800 |
| 16 Agosto 2024 | $0,2800 |
| 10 Maggio 2024 | $0,2800 |
| 23 Febbraio 2024 | $0,2800 |
| 10 Novembre 2023 | $0,2800 |
| 17 Agosto 2023 | $0,2800 |
| 12 Maggio 2023 | $0,2800 |
| 24 Febbraio 2023 | $0,2800 |
| 10 Novembre 2022 | $0,2800 |
| 12 Agosto 2022 | $0,2800 |
| 13 Maggio 2022 | $0,2800 |
| 25 Febbraio 2022 | $0,2800 |
| 19 Novembre 2021 | $0,2800 |
| 20 Agosto 2021 | $0,2800 |
OGN Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
VENDI
13 analisti
- Acquisto forte 0 0,0%
- Compra 0 0,0%
- Mantieni 7 53,8%
- Vendi 5 38,5%
- Vendita forte 1 7,7%
Target Price a 12 Mesi
4 analisti · 2026-06-24
Mediana
$11.50
Ora
$13.47
Basso
$8.00
Alto
$14.00
Target mediano
$11.50
-14,7%
Target medio
$11.25
-16,5%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.00%
Prossimo report
Ago 03, 2026
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 31 Marzo 2026 | $0.71 | $0.84 | -0.13% |
| 31 Dicembre 2025 | $0.63 | $0.73 | -0.10% |
| 30 Settembre 2025 | $1.01 | $0.95 | 0.06% |
| 30 Giugno 2025 | $1.00 | $0.96 | 0.04% |
| 31 Marzo 2025 | $1.02 | $0.91 | 0.11% |
Confronto tra pari Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| OGN | $1.87B | 10.0 | -2.9% | 3.0% | 25.2% | 53.3% |
| INDV | — | 21.9 | 4.3% | 17.0% | -118.3% | 80.2% |
| DFTX | $1.32B | -6.5 | 212.0% | — | -71.0% | — |
| MANE | — | — | — | — | 82.6% | — |
| EWTX | $2.64B | -15.2 | — | — | -30.2% | — |
| CRNX | $4.45B | -9.4 | 640.7% | -6046.2% | -43.0% | — |
| ELVN | $915M | -8.4 | — | — | -21.9% | — |
| GPCR | $14.78B | -86.9 | — | — | -12.3% | — |
| ALMS | — | -3.4 | — | -1011.8% | -61.9% | — |
| TARS | $3.48B | -51.5 | 146.7% | -14.7% | -19.7% | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $6.22B | $6.40B | $6.26B | $6.17B | $6.30B | $6.53B | |
| Cost of Revenue | $2.90B | $2.69B | $2.52B | $2.29B | $2.38B | $2.12B | |
| Gross Profit | $3.31B | $3.71B | $3.75B | $3.88B | · | · | |
| R&D Expense | · | · | · | · | $443M | $210M | |
| SG&A Expense | $1.72B | $1.76B | $1.89B | $1.70B | $1.67B | $1.36B | |
| Interest Expense | $504M | $520M | $527M | $422M | $258M | $0 | |
| Pretax Income | $425M | $807M | $673M | $1.12B | $1.53B | $2.75B | |
| Income Tax | $238M | $-57M | $-350M | $205M | $178M | $496M | |
| Net Income | $187M | $864M | $1.02B | $917M | $1.35B | $2.16B | |
| EPS (Basic) | $0.72 | $3.36 | $4.01 | $3.61 | $5.33 | $8.52 | |
| EPS (Diluted) | $0.72 | $3.33 | $3.99 | $3.59 | $5.31 | $8.52 | |
| Shares (Basic) | 259,495,000 | 257,046,000 | 255,239,000 | 254,082,000 | 253,538,000 | 253,516,000 | |
| Shares (Diluted) | 260,764,000 | 259,152,000 | 256,270,000 | 255,169,000 | 254,193,000 | 253,516,000 |
Stato Patrimoniale 25
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $574M | $675M | $693M | $706M | $737M | $12M | |
| Receivables | $1.33B | $1.36B | $1.74B | $1.48B | $1.38B | $1.04B | |
| Inventory | $1.41B | $1.32B | $1.31B | $1.00B | $915M | $913M | |
| Other Current Assets | $1.03B | $994M | $756M | $747M | $726M | $930M | |
| Current Assets | $4.35B | $4.35B | $4.51B | $3.93B | $3.76B | $3.57B | |
| PP&E (Net) | $1.30B | $1.17B | $1.18B | $1.02B | $973M | $984M | |
| Accum. Depreciation | $1.24B | $1.06B | $1.02B | $902M | $882M | $820M | |
| Goodwill | $4.15B | $4.68B | $4.60B | $4.60B | $4.60B | $4.60B | |
| Intangibles | $1.13B | $1.41B | $533M | $649M | $651M | $503M | |
| Total Assets | $12.87B | $13.10B | $12.06B | $10.96B | $10.68B | $10.11B | |
| Accounts Payable | $952M | $1.15B | $1.31B | $1.13B | $1.38B | $259M | |
| Current Liabilities | $2.39B | $2.72B | $2.92B | $2.51B | $2.60B | $2.67B | |
| Capital Leases | $116M | $112M | $125M | $150M | $184M | $23M | |
| Deferred Tax | $57M | $74M | $47M | $19M | $4M | $128M | |
| Other Non-current Liabilities | $1.01B | $977M | $412M | $411M | $463M | $1.74B | |
| Total Liabilities | $12.12B | $12.63B | $12.13B | $11.85B | · | · | |
| Long-term Debt | $8.64B | $8.88B | $8.76B | $8.91B | $9.13B | $0 | |
| Total Debt | $8.63B | $20M | $8.76B | $8.91B | $9.13B | · | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $0 | |
| Paid-in Capital | · | · | · | · | $0 | $0 | |
| Retained Earnings | $1.11B | $1.01B | $443M | $-331M | $-998M | $0 | |
| AOCI | $-527M | $-649M | $-541M | $-564M | $-513M | $-622M | |
| Stockholders' Equity | $752M | $472M | $-70M | $-892M | $-1.51B | $5.49B | |
| Liabilities + Equity | $12.87B | $13.10B | $12.06B | $10.96B | $10.68B | $10.11B | |
| Shares Outstanding | 260,316,000 | 257,799,000 | 255,626,000 | 254,370,000 | 253,550,000 | · |
Flusso di cassa 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Stock-based Comp | $77M | $105M | $101M | $75M | $59M | $40M | |
| Deferred Tax | $63M | $-160M | $-485M | $-18M | $-288M | $-32M | |
| Amort. of Intangibles | $205M | $145M | $116M | $116M | $103M | $86M | |
| Restructuring | $95M | $31M | $62M | $28M | $3M | $60M | |
| Operating Cash Flow | $700M | $939M | $799M | $858M | $2.16B | $2.28B | |
| CapEx | $162M | $175M | $251M | $196M | $192M | $255M | |
| Investing Cash Flow | $-390M | $-513M | $-260M | $-420M | · | · | |
| Debt Issued | $1.05B | $1.19B | $80M | $0 | $9.47B | $0 | |
| Net Debt Issued | $-458M | $-11M | $-258M | $-108M | $9.36B | · | |
| Dividends Paid | $88M | $297M | $294M | $290M | $145M | $0 | |
| Financing Cash Flow | $-561M | $-368M | $-569M | $-433M | · | · | |
| Net Change in Cash | $-101M | $-18M | $-13M | $-31M | $667M | $-249M | |
| Taxes Paid | $287M | · | · | · | · | · | |
| Free Cash Flow | $538M | $764M | $548M | $662M | $1.97B | · | |
| Levered FCF | $316M | $207M | $-253M | $317M | $1.74B | · |
Redditività 5
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 53.3% | 58.0% | · | · | · | · | |
| Net Margin | 3.0% | 13.5% | 16.3% | 14.8% | 21.4% | · | |
| Pretax Margin | 6.8% | 12.6% | 10.8% | 18.2% | 24.2% | · | |
| ROA | 1.4% | · | 8.9% | 8.5% | 13.0% | · | |
| ROE | 25.2% | · | -310.5% | -93.7% | -86.4% | · |
Liquidità e Solvibilità 4
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | 1.8 | · | 1.5 | 1.6 | 1.4 | · | |
| Quick Ratio | 0.8 | · | 0.8 | 0.9 | 0.8 | · | |
| Debt / Equity | 11.5 | · | -125.1 | -10.0 | -6.1 | · | |
| LT Debt / Equity | 11.5 | · | -125.0 | -10.0 | -6.1 | · |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | · | 0.5 | 0.6 | 0.6 | · | |
| Inventory Turnover | 2.1 | · | 2.2 | 2.4 | 2.6 | · | |
| Receivables Turnover | 4.6 | · | 3.9 | 4.3 | 5.2 | · |
Tassi di Crescita 9
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.9% | 2.2% | 1.4% | -2.1% | -3.5% | · | |
| Revenue CAGR 3Y | 0.23% | 0.52% | -1.4% | · | · | · | |
| Revenue CAGR 5Y | -0.99% | · | · | · | · | · | |
| EPS YoY | -78.4% | -16.5% | 11.1% | -32.4% | -37.7% | · | |
| EPS CAGR 3Y | -41.5% | -14.4% | -22.3% | · | · | · | |
| EPS CAGR 5Y | -39.0% | · | · | · | · | · | |
| Net Income YoY | -78.4% | -15.5% | 11.6% | -32.1% | -37.5% | · | |
| Net Income CAGR 3Y | -41.1% | -13.8% | -22.1% | · | · | · | |
| Net Income CAGR 5Y | -38.7% | · | · | · | · | · |
Valutazione (TTM) 15
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.22B | $6.40B | $6.26B | $6.17B | $6.30B | · | |
| Net Income TTM | $187M | $864M | $1.02B | $917M | $1.35B | · | |
| Market Cap | $1.87B | · | $3.69B | $7.10B | $7.72B | · | |
| Enterprise Value | $9.92B | · | $11.75B | $15.31B | $16.12B | · | |
| P/E | 10.0 | 4.5 | 3.6 | 7.8 | 5.7 | · | |
| P/S | 0.3 | · | 0.6 | 1.2 | 1.2 | · | |
| P/B | 2.5 | · | -52.7 | -8.0 | -5.1 | · | |
| P / Cash Flow | 2.7 | · | 4.6 | 8.3 | 3.6 | · | |
| P / FCF | 3.5 | · | 6.7 | 10.7 | 3.9 | · | |
| EV / FCF | 18.4 | · | 21.4 | 23.1 | 8.2 | · | |
| EV / Revenue | 1.6 | · | 1.9 | 2.5 | 2.6 | · | |
| Dividend Yield | 4.7% | · | 8.0% | 4.1% | 1.9% | · | |
| Earnings Yield | 10.0% | 22.3% | 27.7% | 12.8% | 17.4% | · | |
| Payout Ratio | 47.1% | 34.4% | 28.7% | 31.6% | 10.7% | · | |
| Annual Payout | $88M | $297M | $294M | $290M | $145M | · |
Conto Economico 12
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.46B | $1.51B | $1.60B | $1.59B | $1.51B | $1.59B | $1.58B | $1.61B | $1.62B | $1.60B | $1.52B | $1.61B | $1.54B | $1.49B | $1.54B | $1.58B | |
| Cost of Revenue | $677M | $766M | $745M | $720M | $672M | $696M | $659M | $668M | $665M | $683M | $612M | $640M | $580M | $594M | $551M | $588M | |
| Gross Profit | $783M | $741M | $857M | $874M | $841M | $896M | $923M | $939M | $957M | $915M | $907M | $968M | · | · | · | · | |
| SG&A Expense | $424M | $433M | $415M | $453M | $420M | $470M | $422M | $437M | $431M | $469M | $538M | $451M | $435M | $470M | $440M | $423M | |
| Interest Expense | $111M | $121M | $128M | $131M | $124M | $132M | $126M | $131M | $131M | $129M | $134M | $132M | $132M | $119M | $108M | $98M | |
| Pretax Income | $213M | $-148M | $243M | $229M | $101M | $129M | $207M | $235M | $236M | $104M | $80M | $254M | $235M | $111M | $282M | $287M | |
| Income Tax | $67M | $57M | $83M | $84M | $14M | $20M | $-152M | $40M | $35M | $-442M | $22M | $12M | $58M | $3M | $55M | $53M | |
| Net Income | $146M | $-205M | $160M | $145M | $87M | $109M | $359M | $195M | $201M | $546M | $58M | $242M | $177M | $108M | $227M | $234M | |
| EPS (Basic) | $0.56 | $-0.79 | $0.61 | $0.56 | $0.34 | $0.43 | $1.39 | $0.76 | $0.78 | $2.13 | $0.23 | $0.95 | $0.70 | $0.43 | $0.89 | $0.92 | |
| EPS (Diluted) | $0.55 | $-0.78 | $0.61 | $0.56 | $0.33 | $0.42 | $1.38 | $0.75 | $0.78 | $2.12 | $0.23 | $0.95 | $0.69 | $0.42 | $0.89 | $0.92 | |
| Shares (Basic) | 260,370,000 | -518,281,000 | 259,975,000 | 259,939,000 | 257,862,000 | -513,435,000 | 257,498,000 | 257,288,000 | 255,695,000 | -510,082,000 | 255,588,000 | 255,341,000 | 254,392,000 | -507,867,000 | 254,348,000 | 254,018,000 | |
| Shares (Diluted) | 262,896,000 | -521,046,000 | 260,653,000 | 260,156,000 | 261,001,000 | -517,565,000 | 259,757,000 | 258,598,000 | 258,362,000 | -512,202,000 | 256,349,000 | 255,953,000 | 256,170,000 | -510,106,000 | 255,067,000 | 255,156,000 |
Stato Patrimoniale 24
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $1.12B | $574M | $672M | $599M | $547M | $675M | $763M | $704M | $575M | · | $414M | $326M | $459M | · | $499M | $545M | |
| Receivables | $1.38B | $1.33B | $1.48B | $1.48B | $1.46B | $1.36B | $1.69B | $1.62B | $1.55B | · | $1.65B | $1.67B | $1.45B | · | $1.44B | $1.49B | |
| Inventory | $1.37B | $1.41B | $1.49B | $1.45B | $1.36B | $1.32B | $1.38B | $1.29B | $1.26B | · | $1.19B | $1.20B | $1.12B | · | $879M | $950M | |
| Other Current Assets | $1.06B | $1.03B | $1.06B | $1.08B | $1.00B | $994M | $925M | $901M | $811M | · | $802M | $761M | $755M | · | $774M | $789M | |
| Current Assets | $4.93B | $4.35B | $4.70B | $4.62B | $4.37B | $4.35B | $4.76B | $4.51B | $4.20B | · | $4.05B | $3.96B | $3.78B | · | $3.59B | $3.77B | |
| PP&E (Net) | $1.28B | $1.30B | $1.29B | $1.27B | $1.20B | $1.17B | $1.20B | $1.16B | $1.18B | · | $1.10B | $1.11B | $1.05B | · | $906M | $952M | |
| Accum. Depreciation | · | $1.24B | · | · | · | $1.06B | · | · | · | · | · | · | · | · | · | · | |
| Goodwill | $4.15B | $4.15B | $4.68B | $4.68B | $4.68B | $4.68B | $4.60B | $4.60B | $4.60B | $4.60B | $4.60B | $4.60B | $4.60B | · | $4.60B | $4.60B | |
| Intangibles | $1.10B | $1.13B | $1.34B | $1.36B | $1.42B | $1.41B | $763M | $684M | $718M | · | $561M | $592M | $621M | · | $670M | $638M | |
| Total Assets | $13.00B | $12.87B | $13.55B | $13.50B | $13.16B | $13.10B | $12.75B | $12.15B | $11.89B | · | $11.01B | $10.98B | $10.76B | · | $10.44B | $10.61B | |
| Accounts Payable | $983M | $952M | $1.07B | $1.07B | $1.01B | $1.15B | $1.09B | $1.24B | $955M | · | $1.07B | $1.11B | $996M | · | $1.03B | $1.13B | |
| Current Liabilities | $2.50B | $2.39B | $2.68B | $2.80B | $2.62B | $2.72B | $2.79B | $2.75B | $2.54B | · | $2.49B | $2.39B | $2.35B | · | $2.33B | $2.40B | |
| Capital Leases | · | $116M | · | · | · | $112M | · | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $56M | $57M | $62M | $69M | $69M | $74M | $56M | $60M | $44M | · | $43M | $32M | $30M | · | $43M | $23M | |
| Other Non-current Liabilities | $984M | $1.01B | $1.12B | $1.12B | $994M | $977M | $674M | $548M | $549M | · | $421M | $393M | $421M | · | $441M | $448M | |
| Total Liabilities | $12.09B | $12.12B | $12.65B | $12.77B | $12.61B | $12.63B | $12.26B | $12.01B | $11.84B | · | $11.60B | $11.53B | · | · | · | · | |
| Long-term Debt | $8.57B | $8.64B | $8.83B | $8.90B | $8.96B | $8.88B | $8.75B | $8.66B | $8.71B | · | $8.65B | $8.73B | $8.71B | · | $8.70B | $8.89B | |
| Total Debt | $8.55B | · | $8.78B | · | · | · | $8.75B | $8.66B | $8.71B | · | $8.65B | $8.73B | $8.71B | · | $8.70B | $8.89B | |
| Common Stock | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | · | $3M | $3M | $3M | · | $3M | $3M | |
| Retained Earnings | $1.25B | $1.11B | $1.32B | $1.16B | $1.03B | $1.01B | $975M | $690M | $573M | · | $-16M | $-25M | $-206M | · | $-383M | $-551M | |
| AOCI | $-539M | $-527M | $-574M | $-572M | $-617M | $-649M | $-571M | $-612M | $-577M | · | $-576M | $-533M | $-534M | · | $-686M | $-589M | |
| Stockholders' Equity | $903M | $752M | $906M | $733M | $542M | $472M | $493M | $144M | $48M | $-70M | $-589M | $-555M | $-737M | $-892M | $-1.07B | $-1.14B | |
| Liabilities + Equity | $13.00B | $12.87B | $13.55B | $13.50B | $13.16B | $13.10B | $12.75B | $12.15B | $11.89B | · | $11.01B | $10.98B | $10.76B | · | $10.44B | $10.61B | |
| Shares Outstanding | 262,649,000 | 260,316,000 | 259,983,000 | 259,965,000 | 257,950,000 | 257,799,000 | 257,539,000 | 257,473,000 | 255,847,000 | · | 255,606,000 | 255,568,000 | 254,432,000 | · | 254,364,000 | 254,321,000 |
Flusso di cassa 13
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $19M | $7M | $24M | $22M | $24M | $26M | $25M | $28M | $26M | $27M | $27M | $25M | $22M | $23M | $18M | $19M | |
| Deferred Tax | $3M | $30M | $40M | $10M | $-17M | $10M | $-196M | $21M | $5M | $-489M | $8M | $-7M | $3M | $0 | $-9M | $-5M | |
| Restructuring | $31M | $7M | $0 | $2M | $86M | $8M | $0 | $0 | $23M | $58M | $0 | $0 | $4M | $17M | $11M | $0 | |
| Operating Cash Flow | $225M | $141M | $264M | $220M | $75M | $390M | $141M | $332M | $76M | $397M | $261M | $27M | $114M | $267M | $317M | $151M | |
| CapEx | $37M | $45M | $46M | $39M | $32M | $55M | $42M | $32M | $46M | $79M | $55M | $71M | $46M | $63M | $55M | $45M | |
| Investing Cash Flow | $386M | $-65M | $-115M | $-38M | $-172M | $-296M | $-75M | $-46M | $-96M | $-81M | $-55M | $-70M | $-54M | $-61M | $-213M | $-83M | |
| Debt Issued | $0 | $325M | $300M | $340M | $90M | $150M | $0 | $1.04B | $0 | $0 | $0 | · | · | · | $0 | · | |
| Net Debt Issued | $-32M | · | · | · | · | · | · | · | $-2M | · | · | · | $-252M | · | · | · | |
| Dividends Paid | $5M | $4M | $3M | $10M | $71M | $74M | $74M | $79M | $70M | $73M | $74M | $74M | $73M | $73M | $74M | $72M | |
| Financing Cash Flow | $-38M | $-187M | $-76M | $-223M | $-75M | $-82M | $-78M | $-134M | $-74M | $-77M | $-78M | $-88M | $-326M | $-82M | $-77M | $-183M | |
| Net Change in Cash | $542M | $-98M | $73M | $52M | $-128M | $-88M | $59M | $129M | $-118M | $279M | $88M | $-133M | $-247M | $207M | $-46M | $-149M | |
| Free Cash Flow | $188M | · | · | · | · | · | · | · | $30M | · | · | · | $68M | · | · | · | |
| Levered FCF | $112M | · | · | · | · | · | · | · | $-82M | · | · | · | $-31M | · | · | · |
Redditività 5
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 53.6% | · | 53.5% | · | · | · | 58.3% | 58.4% | · | · | · | · | · | · | · | · | |
| Net Margin | 10.0% | · | 10.0% | · | · | · | 22.7% | 12.1% | 12.4% | · | 3.8% | 15.0% | 11.5% | · | 14.8% | 14.8% | |
| Pretax Margin | 14.6% | · | 15.2% | · | · | · | 13.1% | 14.6% | 14.5% | · | 5.3% | 15.8% | 15.3% | · | 18.4% | 18.1% | |
| ROA | 1.1% | · | 1.2% | · | · | · | 3.0% | 1.7% | 1.8% | · | 0.54% | 2.2% | 1.7% | · | 2.1% | 2.2% | |
| ROE | 20.2% | · | 22.9% | · | · | · | -747.9% | -94.9% | -58.4% | · | -7.0% | -28.6% | -17.8% | · | -16.9% | -15.2% |
Liquidità e Solvibilità 4
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.0 | · | 1.8 | · | · | · | 1.7 | 1.6 | 1.6 | · | 1.6 | 1.7 | 1.6 | · | 1.5 | 1.6 | |
| Quick Ratio | 1.0 | · | 0.8 | · | · | · | 0.9 | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | 0.8 | |
| Debt / Equity | 9.5 | · | 9.7 | · | · | · | 17.7 | 60.1 | 181.5 | · | -14.7 | -15.7 | -11.8 | · | -8.2 | -7.8 | |
| LT Debt / Equity | 9.5 | · | 9.7 | · | · | · | 17.7 | 60.0 | 181.4 | · | -14.7 | -15.7 | -11.8 | · | -8.2 | -7.8 |
Efficienza 3
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.1 | · | · | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Inventory Turnover | 0.5 | · | 0.5 | · | · | · | 0.5 | 0.5 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | |
| Receivables Turnover | 1.0 | · | 1.0 | · | · | · | 0.9 | 1.0 | 1.1 | · | 1.0 | 1.0 | 1.1 | · | 1.0 | 1.1 |
Valutazione (TTM) 13
| Metrica | Tendenza | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6.17B | · | $6.29B | $6.30B | $6.32B | · | $6.33B | $6.36B | $6.29B | · | $6.20B | $6.27B | $6.23B | · | $6.29B | $6.35B | |
| Net Income TTM | $538M | · | $751M | $786M | $842M | · | $813M | $696M | $678M | · | $704M | $880M | $986M | · | $1.13B | $1.33B | |
| Market Cap | $1.57B | · | $2.78B | · | · | · | $4.93B | $5.33B | $4.81B | · | $4.44B | $5.32B | $5.98B | · | $5.95B | $8.58B | |
| Enterprise Value | $9.01B | · | $10.89B | · | · | · | $12.91B | $13.28B | $12.95B | · | $12.68B | $13.72B | $14.24B | · | $14.15B | $16.93B | |
| P/E | 2.9 | · | 3.7 | 3.2 | 4.6 | · | 6.1 | 7.6 | 7.1 | · | 6.3 | 6.0 | 6.1 | · | 5.3 | 6.5 | |
| P/S | 0.3 | · | 0.4 | · | · | · | 0.8 | 0.8 | 0.8 | · | 0.7 | 0.8 | 1.0 | · | 0.9 | 1.4 | |
| P/B | 1.7 | · | 3.1 | · | · | · | 10.0 | 37.0 | 100.2 | · | -7.5 | -9.6 | -8.1 | · | -5.6 | -7.5 | |
| P / Cash Flow | 7.0 | · | · | · | · | · | · | · | 63.3 | · | · | · | 52.5 | · | · | · | |
| P / FCF | 8.4 | · | · | · | · | · | · | · | 160.3 | · | · | · | 88.0 | · | · | · | |
| EV / FCF | 47.9 | · | · | · | · | · | · | · | 431.6 | · | · | · | 209.4 | · | · | · | |
| EV / Revenue | 1.5 | · | 1.7 | · | · | · | 2.0 | 2.1 | 2.1 | · | 2.0 | 2.2 | 2.3 | · | 2.3 | 2.7 | |
| Earnings Yield | 34.2% | · | 27.0% | 31.2% | 21.8% | · | 16.4% | 13.1% | 14.1% | · | 15.9% | 16.6% | 16.4% | · | 19.0% | 15.5% | |
| Payout Ratio | 3.4% | · | · | · | · | · | · | · | 34.8% | · | · | · | 41.2% | · | · | · |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $6.22B | $6.40B | $6.26B | $6.17B | $6.30B |
| Margine Lordo % | 53.3% | 58.0% | — | — | — |
| Utile netto | $187M | $864M | $1.02B | $917M | $1.35B |
| EPS Diluito | $0.72 | $3.33 | $3.99 | $3.59 | $5.31 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Debito / Patrimonio Netto | 11.5 | — | -125.1 | -10.0 | -6.1 |
| Rapporto corrente | 1.8 | — | 1.5 | 1.6 | 1.4 |
| Quick Ratio | 0.8 | — | 0.8 | 0.9 | 0.8 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $538M | $764M | $548M | $662M | $1.97B |
Ultime notizie Notizie recenti che menzionano questa società
- Organon & Co. (OGN) sale a massimo di 52 settimane grazie alla fusione Sun da 11,75 miliardi di dollari
- Sun Pharma si unisce al tavolo dei grandi con l'acquisizione di Organon
- Sun Pharma acquisisce Organon in un accordo da 11,75 miliardi di dollari
- Sun Pharmaceutical Acquista Organon Per 11,75 Miliardi di Dollari
- L'azienda farmaceutica indiana Sun Pharma acquisirà la società statunitense Organon per 11,75 miliardi di dollari
- Organon (OGN) Offerta di Acquisizione Sale a $13 Miliardi, Azioni in Rialzo del 30,9%
- Perché Organon (OGN) ha suscitato voci di acquisizione dopo una brusca rivalutazione
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.